Myomo, Inc. (MYO) stock
MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.92−0.10 (-9.91%)
Close on Nov 17, 2026Market cap $36.40MP/E –Yield –
Myomo operating margin
Operating margin is operating income as a percentage of revenue.
Myomo's operating margin for the twelve months ending Jun 30, 2026 was -27.1%. For fiscal 2025 it was -35.2%, against -19.1% the year before. The highest annual figure on record is -19.1% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -35.2% | −16.1 |
| FY2024 | Dec 31, 2024 | -19.1% | +23.7 |
| FY2023 | Dec 31, 2023 | -42.8% | +25.8 |
| FY2022 | Dec 31, 2022 | -68.6% | +5.5 |
| FY2021 | Dec 31, 2021 | -74.1% | +64.4 |
| FY2020 | Dec 31, 2020 | -138.5% | +142.8 |
| FY2019 | Dec 31, 2019 | -281.3% | +149.5 |
| FY2018 | Dec 31, 2018 | -430.8% | −10.7 |
| FY2017 | Dec 31, 2017 | -420.1% | −123.2 |
| FY2016 | Dec 31, 2016 | -296.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -19.3% | +28.3 |
| Q1 FY2026 | Mar 31, 2026 | -31.2% | +4.6 |
| Q4 FY2025 | Dec 31, 2025 | -24.4% | −22.4 |
| Q3 FY2025 | Sep 30, 2025 | -34.9% | −24.5 |
| Q2 FY2025 | Jun 30, 2025 | -47.6% | −32.7 |
| Q1 FY2025 | Mar 31, 2025 | -35.8% | +67.8 |
| Q4 FY2024 | Dec 31, 2024 | -2.0% | +49.1 |
| Q3 FY2024 | Sep 30, 2024 | -10.4% | +29.5 |
| Q2 FY2024 | Jun 30, 2024 | -14.8% | +3.7 |
| Q1 FY2024 | Mar 31, 2024 | -103.6% | −26.1 |
| Q4 FY2023 | Dec 31, 2023 | -51.2% | +4.0 |
| Q3 FY2023 | Sep 30, 2023 | -39.9% | +31.2 |
| Q2 FY2023 | Jun 30, 2023 | -18.5% | +60.2 |
| Q1 FY2023 | Mar 31, 2023 | -77.5% | −6.7 |
| Q4 FY2022 | Dec 31, 2022 | -55.2% | +12.0 |
| Q3 FY2022 | Sep 30, 2022 | -71.0% | −24.7 |
| Q2 FY2022 | Jun 30, 2022 | -78.7% | +5.0 |
| Q1 FY2022 | Mar 31, 2022 | -70.8% | +54.7 |
| Q4 FY2021 | Dec 31, 2021 | -67.1% | −22.6 |
| Q3 FY2021 | Sep 30, 2021 | -46.3% | +85.8 |
| Q2 FY2021 | Jun 30, 2021 | -83.7% | +248.0 |
| Q1 FY2021 | Mar 31, 2021 | -125.5% | +214.0 |
| Q4 FY2020 | Dec 31, 2020 | -44.5% | +125.2 |
| Q3 FY2020 | Sep 30, 2020 | -132.1% | +333.6 |
| Q2 FY2020 | Jun 30, 2020 | -331.8% | −24.4 |
| Q1 FY2020 | Mar 31, 2020 | -339.5% | −16.3 |
| Q4 FY2019 | Dec 31, 2019 | -169.7% | +137.7 |
| Q3 FY2019 | Sep 30, 2019 | -465.7% | −21.0 |
| Q2 FY2019 | Jun 30, 2019 | -307.4% | +116.7 |
| Q1 FY2019 | Mar 31, 2019 | -323.2% | +444.1 |
| Q4 FY2018 | Dec 31, 2018 | -307.5% | +24.3 |
| Q3 FY2018 | Sep 30, 2018 | -444.7% | −151.0 |
| Q2 FY2018 | Jun 30, 2018 | -424.1% | +206.3 |
| Q1 FY2018 | Mar 31, 2018 | -767.3% | −136.6 |
| Q4 FY2017 | Dec 31, 2017 | -331.7% | −86.9 |
| Q3 FY2017 | Sep 30, 2017 | -293.7% | +213.3 |
| Q2 FY2017 | Jun 30, 2017 | -630.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -630.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -244.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -507.0% | – |
See a number that looks wrong?